UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by GDS Wealth Management

GDS Wealth Management boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 18.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,587 shares of the healthcare conglomerate’s stock after buying an additional 2,096 shares during the period. GDS Wealth Management’s holdings in UnitedHealth Group were worth $7,153,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Bray Capital Advisors raised its holdings in UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after buying an additional 50 shares in the last quarter. Sage Mountain Advisors LLC grew its holdings in UnitedHealth Group by 15.7% during the third quarter. Sage Mountain Advisors LLC now owns 3,528 shares of the healthcare conglomerate’s stock valued at $1,779,000 after purchasing an additional 479 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its holdings in shares of UnitedHealth Group by 2.9% during the 3rd quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 105,860 shares of the healthcare conglomerate’s stock worth $53,374,000 after buying an additional 3,023 shares during the period. Vantage Investment Partners LLC raised its holdings in UnitedHealth Group by 13.4% in the 3rd quarter. Vantage Investment Partners LLC now owns 84,324 shares of the healthcare conglomerate’s stock worth $42,515,000 after acquiring an additional 9,979 shares during the period. Finally, Telemus Capital LLC grew its position in shares of UnitedHealth Group by 2.6% in the third quarter. Telemus Capital LLC now owns 19,338 shares of the healthcare conglomerate’s stock valued at $9,750,000 after purchasing an additional 491 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.8 %

UNH traded up $3.84 during trading on Thursday, reaching $507.05. 2,342,947 shares of the company’s stock were exchanged, compared to its average volume of 4,341,180. The firm has a market capitalization of $466.53 billion, a PE ratio of 30.99, a P/E/G ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company’s fifty day moving average price is $481.55 and its 200-day moving average price is $511.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the firm earned $6.26 earnings per share. The business’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Piper Sandler upped their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research report on Thursday, April 4th. Finally, Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.